Castle (CSTL) Q2 Revenue Tops Estimates
5/8 02:50
Key PointsCastle Biosciences (NASDAQ:CSTL) reported Q2 2025 GAAP earnings per share and non-GAAP revenue that both exceeded analyst estimates by wide margins....
5/8 02:50
Key PointsCastle Biosciences (NASDAQ:CSTL) reported Q2 2025 GAAP earnings per share and non-GAAP revenue that both exceeded analyst estimates by wide margins....